Prostate–Specific Antigen Levels and Clinical Response to Flutamide as the Second Hormone Therapy for Hormone–Refractory Prostate Carcinoma

K Fujikawa, Y Matsui, S Fukuzawa, H Takeuchi - European urology, 2000 - karger.com
Background: Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti–androgen, flutamide, is used together with conventional …
被引用次数：21 相关文章

Prostate-specific antigen levels and clinical response to flutamide as the second hormone therapy for hormone-refractory prostate carcinoma.

K Fujikawa, Y Matsui, S Fukuzawa, H Takeuchi - European Urology, 2000 - europepmc.org
Background Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti-androgen, flutamide, is used together with conventional …

Prostate–Specific Antigen Levels and Clinical Response to Flutamide as the Second Hormone Therapy for Hormone–Refractory Prostate Carcinoma

K Fujikawa, Y Matsui, S Fukuzawa, H Takeuchi - European Urology, 2000 - karger.com
Background: Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti–androgen, flutamide, is used together with conventional …

[引用][C] Prostate–Specific Antigen Levels and Clinical Response to Flutamide as the Second Hormone Therapy for Hormone–Refractory Prostate Carcinoma

K Fujikawa, Y Matsui, S Fukuzawa, H Takeuchi - European Urology, 2000 - cir.nii.ac.jp
Prostate–Specific Antigen Levels and Clinical Response to Flutamide as the Second
Hormone Therapy for Hormone–Refractory Prostate Carcinoma | CiNii Research CiNii …

Prostate-specific antigen levels and clinical response to flutamide as the second hormone therapy for hormone-refractory prostate carcinoma

K Fujikawa, Y Matsui, S Fukuzawa… - European …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Some authors have recently reported that maximum androgen block (MAB), in
which the nonsteroidal anti-androgen, flutamide, is used together with conventional …

[引用][C] Prostate-specific antigen levels and clinical response to Flutamide as the second hormone therapy for hormone-refractory prostate carcinoma

K FUJIKAWA, Y MATSUI, S FUKUZAWA… - European …, 2000 - pascal-francis.inist.fr
Prostate-specific antigen levels and clinical response to Flutamide as the second hormone
therapy for hormone-refractory prostate carcinoma CNRS Inist Pascal-Francis CNRS Pascal …

[引用][C] Prostate-specific antigen levels and clinical response to Flutamide as the second hormone therapy for hormone-refractory prostate carcinoma

K FUJIKAWA, Y MATSUI, S FUKUZAWA, H TAKEUCHI - European urology, 2000 - Elsevier